Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: Highly homologous but distinct in regulation and function

Amino Acids

Volumn 41, Issue 4, 2011, Pages 789-796

  Wolf, Ronald ^a,b   Ruzicka, Thomas ^b   Yuspa, Stuart H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Calcium binding protein; Cancer; Evolution; Inflammation; Innate immunity; Koebnerisin; Paralogs; Psoriasin; RAGE; S100

Indexed keywords

PROTEIN S 100; PROTEIN S 100A15; PSORIASIN; UNCLASSIFIED DRUG;

CARCINOGENESIS; CHROMOSOME 1Q; ENZYME REGULATION; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; NEOPLASM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; SKIN EPITHELIUM; SKIN INFLAMMATION;

AMINO ACID SEQUENCE; CHROMOSOMES, HUMAN, PAIR 1; EPITHELIAL CELLS; HUMANS; INFLAMMATION; MOLECULAR SEQUENCE DATA; NEOPLASMS; S100 PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

PRIMATES;

EID: 83255186286     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-010-0666-4     Document Type: Review

References (54)

1. Abtin A, Eckhart L, Mildner M, Gruber F, Schroder JM et al (2008) Flagellin is the principal inducer of the antimicrobial peptide S100A7c (psoriasin) in human epidermal keratinocytes exposed to Escherichia coli. FASEB J 22(7):2168-2176
2. Alowami S, Qing G, Emberley E, Snell L, Watson PH (2003) Psoriasin (S100A7) expression is altered during skin tumorigenesis. BMC Dermatol 3:1
3. Bianchi R, Giambanco I, Arcuri C, Donato R (2003) Subcellular localization of S100A11 (S100C) in LLC-PK1 renal cells: calcium- and protein kinase c-dependent association of S100A11 with S100B and vimentin intermediate filaments. Microsc Res Tech 60(6):639-651
4. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T et al (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83(11):876-886
5. Boeshans KM, Wolf R, Voscopoulos C, Gillette W, Esposito D et al (2006) Purification, crystallization and preliminary X-ray diffraction of human S100A15. Acta Crystallogr Sect F Struct Biol Cryst Commun 62(Pt 5):467-470
6. 2+-free states. Biochemistry 38(6):1695-1704
7. Broome AM, Eckert RL (2004) Microtubule-dependent redistribution of a cytoplasmic cornified envelope precursor. J Invest Dermatol 122(1):29-38
8. Broome AM, Ryan D, Eckert RL (2003) S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem 51(5):675-685
9. Buchau AS, Hassan M, Kukova G, Lewerenz V, Kellermann S et al (2007) S100A15, an antimicrobial protein of the skin: regulation by E. coli through Toll-like receptor 4. J Invest Dermatol 127(11):2596-2604
10. de Cid R, Riveira-Munoz E, Zeeuwen PL, Robarge J, Liao W et al (2009) Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 41(2):211-215
11. Dempsey AC, Walsh MP, Shaw GS (2003) Unmasking the annexin I interaction from the structure of Apo-S100A11. Structure 11(7): 887-897
12. Donato R (2003) Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 60(6):540-551
13. Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D et al (2004) S100 proteins in the epidermis. J Invest Dermatol 123(1):23-33
14. Emberley ED, Niu Y, Njue C, Kliewer EV, Murphy LC et al (2003) Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer. Clin Cancer Res 9(7):2627-2631
15. Emberley ED, Murphy LC, Watson PH (2004a) S100A7 and the progression of breast cancer. Breast Cancer Res 6(4):153-159
16. Emberley ED, Alowami S, Snell L, Murphy LC, Watson PH (2004b) S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast. Breast Cancer Res 6(4):R308-R315
17. Eyerich K, Pennino D, Scarponi C, Foerster S, Nasorri F et al (2009) IL-17 in atopic eczema: linking allergen-specific adaptive and microbial triggered innate immune response. J Allergy Clin Immunol 123(1):59-66 e54
18. Glaser R, Harder J, Lange H, Bartels J, Christophers E et al (2005) Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 6(1):57-64
19. Glaser R, Meyer-Hoffert U, Harder J, Cordes J, Wittersheim M et al (2009) The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 129(3):641-649
20. Grewe M, Bruijnzeel-Koomen CA, Schopf E, Thepen T, Langeveld- Wildschut AG et al (1998) A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19(8):359-361
21. Hardas BD, Zhao X, Zhang J, Longqing X, Stoll S et al (1996) Assignment of psoriasin to human chromosomal band 1q21: coordinate overexpression of clustered genes in psoriasis. J Invest Dermatol 106(4):753-758
22. Heizmann CW, Fritz G, Schafer BW (2002) S100 proteins: structure, functions and pathology. Front Biosci 7:d1356-d1368
23. Kohn EC, Liotta LA (1995) Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55(9):1856-1862
24. Kulski JK, Lim CP, Dunn DS, Bellgard M (2003) Genomic and phylogenetic analysis of the S100A7 (Psoriasin) gene duplications within the region of the S100 gene cluster on human chromosome 1q21. J Mol Evol 56(4):397-406
25. Lee KC, Eckert RL (2007) S100A7 (Psoriasin)-mechanism of antibacterial action in wounds. J Invest Dermatol 127(4):945-957
26. Liu J, Li X, Dong GL, Zhang HW, Chen DL et al (2008) In silico analysis and verification of S100 gene expression in gastric cancer. BMC Cancer 8:261
27. Madsen P, Rasmussen HH, Leffers H, Honore B, Dejgaard K et al (1991) Molecular cloning, occurrence, and expression of a novel partially secreted protein ''psoriasin'' that is highly up-regulated in psoriatic skin. J Invest Dermatol 97(4):701-712
28. Martinsson H, Yhr M, Enerback C (2005) Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation. Exp Dermatol 14(3):161-168
29. Mischke D, Korge BP, Marenholz I, Volz A, Ziegler A (1996) Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex (''epidermal differentiation complex'') on human chromosome 1q21. J Invest Dermatol 106(5):989-992
30. 2+ are essential for S100A12 protein oligomerization and function. BMC Biochem 10:11
31. Moubayed N, Weichenthal M, Harder J, Wandel E, Sticherling M et al (2007) Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol 133(4): 253-261
32. Numerof RP, Asadullah K (2006) Cytokine and anti-cytokine therapies for psoriasis and atopic dermatitis. BioDrugs 20(2): 93-103
33. Ramasamy R, Yan SF, Herold K, Clynes R, Schmidt AM (2008) Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis. Ann N Y Acad Sci 1126:7-13
34. Robinson NA, Lapic S, Welter JF, Eckert RL (1997) S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes. J Biol Chem 272(18):12035-12046
35. Ruse M, Broome AM, Eckert RL (2003) S100A7 (psoriasin) interacts with epidermal fatty acid binding protein and localizes in focal adhesion-like structures in cultured keratinocytes. J Invest Dermatol 121(1):132-141
36. Sabat R, Philipp S, Hoflich C, Kreutzer S, Wallace E et al (2007) Immunopathogenesis of psoriasis. Exp Dermatol 16(10):779-798
37. Santilli F, Vazzana N, Bucciarelli LG, Davi G (2009) Soluble forms of RAGE in human diseases: clinical and therapeutical implications. Curr Med Chem 16(8):940-952
38. Schroder JM, Harder J (2006) Antimicrobial skin peptides and proteins. Cell Mol Life Sci 63(4):469-486
39. Semprini S, Capon F, Bovolenta S, Bruscia E, Pizzuti A et al (1999) Genomic structure, promoter characterisation and mutational analysis of the S100A7 gene: exclusion of a candidate for familial psoriasis susceptibility. Hum Genet 104(2):130-134
40. Semprini S, Capon F, Tacconelli A, Giardina E, Orecchia A et al (2002) Evidence for differential S100 gene over-expression in psoriatic patients from genetically heterogeneous pedigrees. Hum Genet 111(4-5):310-313
41. Sourris KC, Forbes JM (2009) Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy-are these receptors valid therapeutic targets. Curr Drug Targets 10(1): 42-50
42. South AP, Cabral A, Ives JH, James CH, Mirza G et al (1999) Human epidermal differentiation complex in a single 2.5 Mbp long continuum of overlapping DNA cloned in bacteria integrating physical and transcript maps. J Invest Dermatol 112(6):910-918
43. Steinert PM, Kim SY, Chung SI, Marekov LN (1996) The transglutaminase 1 enzyme is variably acylated by myristate and palmitate during differentiation in epidermal keratinocytes. J Biol Chem 271(42):26242-26250
44. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC et al (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405(6784):354-360
45. Wolf R, Mirmohammadsadegh A, Walz M, Lysa B, Tartler U et al (2003) Molecular cloning and characterization of alternatively spliced mRNA isoforms from psoriatic skin encoding a novel member of the S100 family. FASEB J 17(13):1969-1971
46. Wolf R, Lewerenz V, Buchau AS, Walz M, Ruzicka T (2007) Human S100A15 splice variants are differentially expressed in inflammatory skin diseases and regulated through Th1 cytokines and calcium. Exp Dermatol 16(8):685-691
47. Wolf R, Howard OM, Dong HF, Voscopoulos C, Boeshans K et al (2008) Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. J Immunol 181(2):1499-1506
48. Wolf R, Voscopoulos C, Winston J, Dharamsi A, Goldsmith P et al (2009) Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancer. Cancer Lett 277(1):101-107
49. Yan SD, Bierhaus A, Nawroth PP, Stern DM (2009) RAGE and Alzheimer's disease: a progression factor for amyloid-betainduced cellular perturbation? J Alzheimers Dis 16(4):833-843
50. Yao R, Lopez-Beltran A, Maclennan GT, Montironi R, Eble JN et al (2007) Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res 27(5A):3051-3058
51. Zen K, Chen CX, Chen YT, Wilton R, Liu Y (2007) Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium. J Immunol 178(4):2483-2490
52. Zhang H, Wang Y, Chen Y, Sun S, Li N et al (2007) Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain. Lung Cancer 57(1):37-45
53. Zhang XJ, Huang W, Yang S, Sun LD, Zhang FY et al (2009) Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet 41(2):205-210
54. Zimmer DB, Wright Sadosky P, Weber DJ (2003) Molecular mechanisms of S100-target protein interactions. Microsc Res Tech 60(6):552-559